Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Local Delivery of Paclitaxel for Prevention of Restenosis in Hemodialysis Access

NCT01001676 is registered in ClinicalTrials.gov with University Health Network, Toronto as lead sponsor.

NCT NCT01001676
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01001676 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Local Delivery of Paclitaxel for Prevention of Restenosis in Hemodialysis Access
Lead sponsor
University Health Network, Toronto
Phase
Phase 2
Overall status
Completed
Start date
February 29, 2012
Completion date
July 31, 2014
Enrollment
32 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

renal failure